---
title: "YZYBIO-B: Wang Tao elected as employee representative supervisor"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/257868601.md"
description: "According to the Zhitong Finance APP, YZYBIO-B announced that Mr. Zhang Jing resigned from his position as employee representative supervisor of the company for personal career development reasons, effective September 18, 2025. Dr. Wang Tao, Executive Director of the company's R&D Platform Department, was democratically elected as the employee representative supervisor of the second supervisory board on September 18, 2025. Dr. Wang Tao's term will be effective from September 18, 2025, and will expire at the end of the second supervisory board"
datetime: "2025-09-18T08:53:03.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/257868601.md)
  - [en](https://longbridge.com/en/news/257868601.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/257868601.md)
generator: "portal-rs"
---

# YZYBIO-B: Wang Tao elected as employee representative supervisor

According to the announcement from Zhitong Finance APP, YZYBIO-B (02496) announced that Mr. Zhang Jing has resigned from his position as the employee representative supervisor of the company for personal career development reasons, effective from September 18, 2025.

Dr. Wang Tao, Executive Director of the R&D Platform Department, was democratically elected as the employee representative supervisor of the second supervisory board on September 18, 2025. Dr. Wang Tao's term will be effective from September 18, 2025, and will expire at the end of the second supervisory board

### Related Stocks

- [02496.HK](https://longbridge.com/en/quote/02496.HK.md)

## Related News & Research

- [RemeGen files board, board committee member list with disclosure responsibilities](https://longbridge.com/en/news/296803857.md)
- [Abbisko Cayman seeks name change to Abbisko Medicine Co](https://longbridge.com/en/news/296795772.md)
- [Brii Biosciences files HKEX next-day disclosure, lifts share capital by 255,793 shares](https://longbridge.com/en/news/296801683.md)
- [Abbisko turns to IFRS net loss of RMB 193.47 million in FY26 H1; revenue drops 84% to RMB 97.27 million](https://longbridge.com/en/news/296795302.md)
- [AFYREN scales bio-based acid output and strengthens climate-resilient positioning](https://longbridge.com/en/news/297214424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**